Beneficial Effects of GLP-1 Agonist in a Male With Compulsive Food-Related Behavior Associated With Autism

Glucagon-like peptide 1 in health and disease

(2018) Andreas Andersen et al.   Nature Reviews Endocrinology

Effects of incretin-based therapies on neurocognitive function in humans: A systematic review of the literature

(2018) Jonathan L. Dumbrill et al.   Primary Care Diabetes

Discovery, characterization, and clinical development of the glucagon-like peptides

(2017) Daniel J. Drucker et al.   JOURNAL OF CLINICAL INVESTIGATION

Anxiety Disorders and Obsessive-Compulsive Disorder in Individuals with Autism Spectrum Disorder

(2017) Valentina Postorino et al.   Current Psychiatry Reports

Compulsivity in obsessive–compulsive disorder and addictions

(2016) Martijn Figee et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) – study protocol for a randomised controlled trial

(2016) Alexander Häge et al.   Trials

Striatal Circuits as a Common Node for Autism Pathophysiology

(2016) Marc V. Fuccillo   Frontiers in Neuroscience

The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents

(2015) Daniel Vallöf et al.   ADDICTION BIOLOGY

Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes

(2015) Jennifer S. ten Kulve et al.   DIABETOLOGIA

Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain

(2015) Simon C. Cork et al.   Molecular Metabolism

Obsessive-Compulsive Disorder and Autism Spectrum Disorders: Longitudinal and Offspring Risk

(2015) Sandra M Meier et al.   PLoS One

Use of GLP-1 Receptor Agonists in Prader-Willi Syndrome: Report of Six Cases

(2014) Danilo Fintini et al.   DIABETES CARE

The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome

(2012) Miho Senda et al.   ENDOCRINE JOURNAL

A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders

(2011) Eric Hollander et al.   AMERICAN JOURNAL OF PSYCHIATRY

Effects of a Single Dose of Exenatide on Appetite, Gut Hormones, and Glucose Homeostasis in Adults with Prader-Willi Syndrome

(2011) Lisa Sze et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism

(2011) Karen L. Teff et al.   PHYSIOLOGY & BEHAVIOR